Effects of current therapy of Kawasaki disease on eicosanoid metabolism
- 1 June 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 61 (15) , 1323-1327
- https://doi.org/10.1016/0002-9149(88)91177-0
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Kawasaki SyndromePediatric Clinics of North America, 1986
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984
- Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of coronary artery aneurysmsThe Journal of Pediatrics, 1984
- Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritisThe Journal of Pediatrics, 1984
- Platelets and Prostaglandins in Coronary Artery DiseasePublished by American Medical Association (AMA) ,1983
- Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki diseaseThe Journal of Pediatrics, 1983
- Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term follow-up studyThe American Journal of Cardiology, 1982
- Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep.Circulation Research, 1982
- Role of Thromboxane and Prostacyclin in Pulmonary Vasomotor Changes after Endotoxin in DogsJournal of Clinical Investigation, 1981